Femme et Homme
- | Pays :
- Denmark
- Hungary
- Poland
- Les 2 autres...
- | Organes : -
- | Spécialités : -
Extrait
A 3-year open-label trial for patients who previously participated in Trial Hx-CD20-403 and who fulfill the eligibility criteria for this trial (GEN413) . Th e primary purpose of the trial is to evaluate the long-term effectiveness of repeated courses ( a maximum of 9 treatment courses) of ofatumumab in RA patients who previously received ofatumumab or placebo in Trial Hx-CD20-403.
Critère d'inclusion
- Arthritis (rheumatoid)